Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Journal of Neural Transmission|January 1, 1986
In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brainE Pileblad, A CarlssonJournal of Neurochemistry|December 1, 1989
Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathioneE Pileblad, T MagnussonLife Sciences|January 1, 1990
Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-oneE Pileblad, T MagnussonNeuropharmacology|January 1, 1987
The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brainE Pileblad, A CarlssonBiochemical Pharmacology|September 1, 1992
Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteineE Pileblad, T MagnussonNaunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1986
GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studiesE Pileblad, G EngbergNeuropharmacology|July 1, 1985
Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brainE Pileblad, A CarlssonPharmacology & Toxicology|April 1, 1988
Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)E Pileblad, A CarlssonNaunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1991
The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigraH Nissbrandt, G Engberg, E PilebladUrology|November 1, 1995
Impact of competing mortality on the cancer-related mortality in localized prostate cancerG Aus, E Pileblad, J HugossonPageof 3